Samyang Biopharm specializes in marketing initial generics and drug delivery system (DDS)-based adjusted medications for cancer therapy and the creation of small-molecule medications, novel biologic medications, and cancer virus vaccines. They are exporting their oncology products to over 25 different countries, and their cytotoxic manufacturing facility is authorized by regulatory bodies in South Korea.
Products & Services
Bortezomib Triad
CDMO service
Docetaxel
Docetaxel Anhydrous
Sites
SAMYANG BIOPHARMACEUTICALS
Country
South KoreaCity
Daejeon
SAMYANG BIOPHARMACEUTICALS
Country
South KoreaCity
Daejeon
Samyang Holdings
Country
South KoreaSamyang Biopharmaceuticals
Country
South KoreaCity
Seongnam-si
Samyang Holdings
Country
South Korea